In a recent issue of the Annals of Internal Medicine, researchers found that Ketek (telithromycin), the antibiotic that treats upper respiratory infections, may be linked to more than just liver disease but may also be responsible for the development of hepatitis.The U.S. Food and Drug Administration (FDA) approved Ketek from Sanofi-Aventis in 2004 to treat the following illnesses:* acute bacterial infections* chronic bronchitis* acute bacterial sinusitis* community-acquired pneumoniaUnfortunately, the drug was recently linked to severe liver failure and liver disease development among patients, however, because it also caused a case of drug-induced hepatitis, it may be critical for scientists and medical professionals to look further into the development of hepatitis as a potential side effect as well.What is Hepatitis?The U.S. Hepatitis is the swelling of the liver when poisons and foods are not able to be properly digested, stored or removed from the body, according to the National Institutes of Health’s (NIH) National Library of Medicine (NLM). According to the NLM, hepatitis can be treated with drugs, however, it can also last a lifetime in which case an individual must re-evaluate their lifestyle to accommodate the following:* do not share food* do not donate blood, plasma, sperm, tissue or body […]

Full Article At: KnowHow-Now.com Articles

Bookmark to: